the dual agonist thing finally clicked for me and I want to write it down
Posting this as a discussion rather than a claim: the dual agonist thing finally clicked for me and I want to write it down.
16kg over 37 weeks, never went past 10mg, and nausea stayed mild the whole way. Posting because the loud threads are all 15mg.
Week 78 was the first time the scale moved after a five-week stall. I changed nothing in that window.
The thing nobody warned me about was how much of this is logistics — storing it, remembering it, the same day every week.
Would rather be corrected in public than confident in private.
best — the order this archive was captured in
It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.
Disagree with the conversion table. There is no validated equivalence between the two molecules and posting one as though there is does real damage.
Left up, flair changed to Discussion. It is an opinion post and that is fine as long as it is labelled.
Pen or vial? The step sizes available differ and it changes this answer.
The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.
Yes. I stepped to 12.5 because the calendar said so, not because anything needed fixing, and I regretted it for a fortnight.
Careful with "everyone tolerates it better". The people it did not suit stop posting, which makes this board look calmer than the drug is.
The 21% figure is a 72-week mean on the highest arm. Quoting it as what someone should expect by week 30 is not a fair reading.
Are you comparing yourself with the trial mean or with the people who post the most?
Which week did the appetite change actually land for you?
Does injection-site soreness follow the day after the shot, or is it spread across the week?